Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
760
NCT03559166
First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 11, 2018
Completion: Oct 4, 2019
NCT04244825
Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF
Phase: Phase 2
Start: Dec 15, 2019
Completion: Nov 5, 2020
NCT04146805
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
Start: Jan 10, 2020
Completion: Apr 12, 2021
NCT04334460
Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects
Start: May 4, 2020
Completion: Jun 21, 2021
NCT04707989
Tolerance and Safety of a Ketone-Promoting Food Ingredient
Phase: N/A
Start: Dec 11, 2020
Completion: Mar 5, 2021
NCT04001998
Healthy Volunteer Study Comparing Tablet and Capsule Formulations
Start: Feb 28, 2021
Completion: Jul 31, 2021
NCT04814498
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Start: May 3, 2021
Completion: Jan 11, 2022
NCT04814472
Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations
Start: May 16, 2021
Completion: Nov 3, 2021
NCT04939467
Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Start: Oct 15, 2021
Completion: Apr 1, 2022
NCT05310058
Pharmacokinetics of C6 Ketone Di-ester
Start: Apr 11, 2022
Completion: Aug 23, 2022
NCT05373914
RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Start: May 31, 2022
Completion: Mar 31, 2024
NCT05686083
Pharmacokinetics of Two Fatty Acid Ketone Esters
Start: Jan 30, 2023
Completion: Mar 31, 2023